was held on 11 May 2018 at 18.00 hrs., the Company would like to notify the significant resolution of the meeting, as follows: The Board of Directors’ meeting has resolved to approve Sapphire RoRo
still lower than 15 percent. Transaction size: The transaction size of asset acquisition above is less than 15 percent. The Board of Directors is authorized to approve the operation and do not have to
With reference to the Board of Directors of the Company in meeting No.3/2019 held on 14 August 2019, the Board has passed the resolution to approve the transactions with details as follows 1.1 Details of
approve the entering into the transaction, and the company has to disclose information to the Stock Exchange of Thailand. 5. Conditions of entry into the transaction The Board of Directors must approve the
Meeting of Shareholders to consider and approve the Company’s and its subsidiaries’ reports and the consolidated financial statements for the fiscal year ended March 31, 2018; 3. Approved to proposed to the
that the Board of Directors Meeting No. 3/2018 which held on 23 March 2018 (the Meeting) has resolved to approve plan to spin-off UAC Advance Polymer & Chemicals Company Limited (UAPC), subsidiary
on 30 March 2018, the Company would like to inform the resolutions of the Board of Directors' Meeting as follows: 1. To approve Takuni Land Company Limited ("Takuni Land"), which is 99.99% subsidiary
, the Company would like to inform the resolutions of the Board of Directors' Meeting as follows: 1. To approve to propose approval at Extraordinary Shareholders’ Meeting of the Company for CAZ (Thailand
Board of Directors’ Meeting No. 1/ 2018 of Rajthanee Hospital Public Company Limited ( the “Company”) held on 26 February 2018 resolved to approve the acquisition of additional shares in the subsidiaries